Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bluejay Diagnostics, Inc.BJDX · Entity 8627 | Director | August 17, 2026 | August 18, 2026 |
| Cipher Digital Inc.GWAC · Entity 3786 | Director | March 10, 2021 | April 20, 2021 |
| Good Works II Acquisition Corp.GWII · Entity 125431 | Director · CEO | July 08, 2022 | July 12, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bluejay Diagnostics, Inc.
Report date August 17, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.08 · Expires 2031-08-17 | Direct | 100,000 |
Reported balance
After 2026-08-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-17 · Grant · Acquired 100,000 · Balance 100,000 F1: Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device.
Cipher Digital Inc.
Report date March 10, 2021 · Filed April 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 195,000 |
Ending reported balance
After 2021-03-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-03-10 · Gift · Disposed 250,000 · Balance 125,000 F1: On or about the transaction date, the reporting person donated 250,000 shares of Issuer common stock to a charitable organization, and received for no consideration 70,000 shares of Issuer common stock from certain officers and directors, and the sponsor of, the Issuer. Row 2 · 2021-03-10 · Gift · Acquired 70,000 · Balance 195,000 F1: On or about the transaction date, the reporting person donated 250,000 shares of Issuer common stock to a charitable organization, and received for no consideration 70,000 shares of Issuer common stock from certain officers and directors, and the sponsor of, the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: On or about the transaction date, the reporting person donated 250,000 shares of Issuer common stock to a charitable organization, and received for no consideration 70,000 shares of Issuer common stock from certain officers and directors, and the sponsor of, the Issuer.
Good Works II Acquisition Corp.
Report date July 08, 2022 · Filed July 12, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 350,000 |
Reported balance
After 2022-07-08 transaction · row 1
1 source rowRow 1 · 2022-07-08 · Gift · Disposed 50,000 · Balance 350,000 F1: On or about the transaction date, the reporting person transferred 50,000 shares of Issuer common stock to a director of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: On or about the transaction date, the reporting person transferred 50,000 shares of Issuer common stock to a director of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 18, 2026 20:16 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.08 | $0.00 |
DisclosureSEC source: 0001123292-26-001126 · form4.xml · derivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-08-17 F1 · derivative.exercise_date: Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device. Read SEC document |
| March 14, 2026 Filed May 18, 2026 21:21 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | PurchaseCommon Stock | 12,500 | $2.00 | $25,000.00 |
DisclosureSEC source: 0001123292-26-000690 · form4.xml · nonDerivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,608 F1 · shares: On March 14, 2026, Mr. Wurth purchased 12,500 shares of the issuer's common stock ("Common Stock") from the issuer in a private placement at a price of $2.00 per share. F2 · ownership.direct: Of such amount, 34 shares of Common Stock are held by Wurth Holdings LLC, an entity controlled by Mr. Wurth. Read SEC document |
| February 01, 2023 Filed Feb 13, 2023 22:32 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | GrantCommon Stock | 27,500 | $0.44 | $12,100.00 |
DisclosureSEC source: 0001213900-23-010875 · ownership.xml · nonDerivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,313,849 Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 17:00 UTC | Good Works II Acquisition Corp. GWII · Entity 125431 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-038900 · ownership.xml · nonDerivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 F1 · price: On or about the transaction date, the reporting person transferred 50,000 shares of Issuer common stock to a director of the Issuer. Read SEC document |
| March 22, 2022 Filed Mar 23, 2022 22:14 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | GrantOption to purchase common stock · Derivative | 2,500 | Not disclosed Strike: $1.26 | Not disclosed |
DisclosureSEC source: 0001213900-22-014582 · ownership.xml · derivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,728 Underlying: Common Stock · 2,500 shares Expires 2032-03-22 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. F3 · balance_after: Includes warrants to purchase 69,868 shares of common stock held indirectly by Wurth Holdings, LLC and options to purchase 157,360 shares of common stock held directly by the reporting person. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 18:04 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | PurchaseCommon Stock | 40,000 | $1.18 | $47,120.00 |
DisclosureSEC source: 0001213900-22-013510 · ownership.xml · nonDerivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,286,349 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.15 to $1.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Does not include 1,108,883 shares held indirectly by Wurth Holdings, LLC. Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 13:00 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | PurchaseCommon Stock | 60,000 | $1.09 | $65,400.00 |
DisclosureSEC source: 0001213900-22-013129 · ownership.xml · nonDerivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,246,349 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.01 to $1.15. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Does not include 1,108,883 shares held indirectly by Wurth Holdings, LLC. Read SEC document |
| January 10, 2022 Filed Jan 14, 2022 00:33 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | GrantOption to purchase common stock · Derivative | 25,000 | Not disclosed Strike: $2.79 | Not disclosed |
DisclosureSEC source: 0001213900-22-002009 · ownership.xml · derivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,228 Underlying: Common Stock · 25,000 shares Expires 2032-01-10 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. F3 · balance_after: Includes warrants to purchase 69,868 shares of common stock held indirectly by Wurth Holdings, LLC and options to purchase 157,360 shares of common stock held directly by the reporting person. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:56 UTC | Good Works II Acquisition Corp. GWII · Entity 125431 | GiftCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-059613 · ownership.xml · nonDerivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 F1 · price: On or about the transaction date, the reporting person donated 250,000 shares of Issuer common stock to certain charitable organizations. Read SEC document |
| March 10, 2021 Filed Apr 20, 2021 00:23 UTC | Cipher Digital Inc. GWAC · Entity 3786 | GiftCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-022182 · ownership.xml · nonDerivative · entry 2 Wurth Douglas Clark · CIK 0001830551 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 F1 · price: On or about the transaction date, the reporting person donated 250,000 shares of Issuer common stock to a charitable organization, and received for no consideration 70,000 shares of Issuer common stock from certain officers and directors, and the sponsor of, the Issuer. Read SEC document |
| March 10, 2021 Filed Apr 20, 2021 00:23 UTC | Cipher Digital Inc. GWAC · Entity 3786 | GiftCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-022182 · ownership.xml · nonDerivative · entry 1 Wurth Douglas Clark · CIK 0001830551 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · price: On or about the transaction date, the reporting person donated 250,000 shares of Issuer common stock to a charitable organization, and received for no consideration 70,000 shares of Issuer common stock from certain officers and directors, and the sponsor of, the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.